Thought Leadership & Other Media

David Self

Recent Posts by David Self:

AGC Biologics is Attending ASGCT May 11-14, 2021 and Presenting Our Scalable LVV Production Process and Large-Scale AAV Manufacturing Development Data

Events Cell & Gene Therapy

We're pleased to announce that we will be attending ASGCT this year, running virtually from May 11 through the 14. Be sure to save some time to meet with our team, check out our two abstracts and presentations on lentiviral vector (LVV) and adeno-associated virus (AAV) – both of which we're thrilled to share with you and the community.  

AGC Biologics Launches Four TV Commercials About Recruiting in the Greater Denver Area: Now Hiring Across All Departments in Boulder, Co.

Other Media Company News

We're thrilled to announce the launch of our first ever television commercials – now running in the Greater Denver Area and focused on recruiting for our new  state-of-the-art facility in Boulder, Colorado. We have begun full-scale operations and are hiring across all departments. To learn more and apply, please visit our Boulders Careers page.

On-Demand Webinar: Large-Scale LVV Production: Industry-Leading Process Development to High Quality GMP Vector

Thought Leadership Cell & Gene Therapy

The on-demand webinar and Q&A “Large-Scale LVV Production: From Industry-Leading Process Development to High Quality GMP Vector,” with our own Giuliana Vallanti, Director of Development and Global R&D, Cell and Gene Therapy, and the panel of co-hosts is now available to watch for free.

On-Demand Roundtable: Streaming and Optimizing Viral Vector Bioprocess and Analytical Development

Thought Leadership Cell & Gene Therapy

Join AGC Biologics' own Mark Womack, Chief Business Officer and Ramin Baghirzade, Sr. Director and Global Cell and Gene Therapy (C&GT) Business Development, and a panel of co-hosts for an on-demand presentation of the C&GT Expert Roundtable on Streaming and Optimizing Viral Vector Bioprocess and Analytical Development, presented by BioInsights.

Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy

Events Thought Leadership Cell & Gene Therapy

Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020. 

Article: Process Development: How to Win the Race in Cell & Gene Therapy

Thought Leadership Cell & Gene Therapy

In this spotlight article, presented by BioInsights, Dr. Ramin Baghirzade, AGC Biologics' Global Head of Business Development for Cell & Gene Therapy, shares his expert insights on the state of the industry, and four inter-connected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.

Follow Us
Join us on LinkedIn Follow us on Twitter